Amphorna Biosciences focuses on targeted RNA therapeutics and delivery technologies. Our research brings together RNA design, antibody–oligonucleotide conjugates (AOCs), and targeted lipid nanoparticles to explore potential therapeutic approaches for fibrosis, oncology, and immunology. Grounded in rigorous science, we aim to translate molecular innovation into solutions that address unmet medical needs.
Officially established in 2026
We are always seeking exceptional scientists, drug hunters, and partners.